A Smart + Strong Site
Subscribe to:
E-newsletters
POZ magazine
JOIN AIDSMEDS YouTube

Back to home » Treatment News » Top Stories

Most Popular Stories
An Almost Normal Life Expectancy for People With HIV?
Undetectable Viral Load Essentially Eliminates Transmission Risk in Straight Couples
A 15-Year Jump in Life Expectancy for People With HIV
Misleading News Reports Suggest HIV Cure Is Near
New HIV Drug Class Shows Promise
Gene Therapy Shows Promise in Controlling HIV
Potential Microbicide Tricks HIV Into Sudden Death
What's That Mean?
(just double-click it!)

If you don't understand one of the words in this article, just double-click it. A window will open with a definition from mondofacto's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:

Most Popular Lessons
Aging & HIV
The HIV Life Cycle
Shingles
Herpes Simplex Virus
Syphilis & Neurosyphilis
Treatments for Opportunistic Infections (OIs)
What is AIDS & HIV?
More News

Have medical or treatment news about HIV? Send press releases, news tips and other announcements to news@aidsmeds.com.

Click here for more news


emailprint

October 4, 2012

Cardiovascular Disease Risk Remains High in HIV Elite Controllers

More evidence that immune activation and inflammation are key drivers of the increased cardiovascular disease risk among people living with HIV: Elite controllers—a rare subset of HIV-positive individuals who maintain undetectable viral loads and high CD4 cell counts in the absence of antiretroviral therapy—have significant plaque hardening of the arteries (atherosclerosis), according to the results of a study published online ahead of print by the journal AIDS.

“We demonstrate an unexpectedly high degree of coronary atherosclerosis and elevated markers of immune activation in [elite controllers],” the Harvard University-affiliated researchers wrote. “Interestingly, the degree of atherosclerosis was similar, if not greater, compared to [people living with HIV] receiving long-term [antiretroviral therapy] with suppressed viremia.”

The study enrolled 10 HIV elite controllers, 103 people living with HIV with undetectable viral loads while receiving antiretroviral therapy and 49 HIV-negative individuals.

The prevalence of arterial plaques was 78 percent among the elite controllers, compared with 42 percent of the HIV-negative study volunteers.  Among those with HIV infection receiving treatment, the prevalence was 60 percent.

The researchers conclude that the “precise interplay” between immune activation, the highly effective HIV-specific T-cell responses that differentiate many of those with elite control of the virus and those with chronic infection, low-level HIV replication and cardiovascular disease “need to be fully elucidated in larger studies” of elite controllers.

To read the AIDS report, click here (paid subscription required).

Search: hiv, elite controllers, long-term nonprogressors, inflammation, immune activation, cardiovascular disease, cvd, atherosclerosis


Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The AIDSmeds team reviews all comments before they are posted. Please do not include ":" "@" "<" ">" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Show comments (1 total)


[Go to top]

Quick Links
AIDSmeds en Español
About HIV and AIDS
Lab Tests
Clinical Trials
HIV Meds
Starting Treatment
Switching Treatment
Drug Resistance
Side Effects
Disclosure
Lipodystrophy
Hepatitis & HIV
Women & Children
Fact Sheets
Treatment News
Community Forums
Blogs
Conference Coverage
Health Services Directory
POZ Magazine


    chipper52
    Palm Springs
    California


    romanticseattle
    Tacoma
    Washington


    OahuAJ
    Turlock
    California


    blaze11212
    brooklyn
    New York
Click here to join POZ Personals!
Conference Coverage

21st Conference on Retroviruses and Opportunistic Infections
(CROI 2014)
Boston, MA
March 3 - 7, 2014


7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention
(IAS 2013)
Kuala Lumpur, Malaysia
June 30 - July 3, 2013


20th Conference on Retroviruses and Opportunistic Infections
(CROI 2013)
Atlanta, GA
March 3 - 7, 2013


more conference coverage

[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.